Skip to main content

An update on an incident involving one of our systems

Hide
Quest Diagnostics

Proteomic Determinants of Variation in Cholesterol Efflux: Observations From the Dallas Heart Study

Proteomic Determinants of Variation in Cholesterol Efflux: Observations From the Dallas Heart Study

Authors: Pearce RW, Collier TS, McPhaul MJ

Citation: Int J Mol Sci. 2023 Oct 24;24(21):15526. doi: 10.3390/ijms242115526

Specialties: Cardiology, Endocrinology

Related content

Conference Presentation
HDL Containing Specific Proteins Blunts the Association with Cholesterol Efflux Capacity: Observations from the Dallas Heart Study
On-Demand Webinar
Cardiovascular Clinical Conversations: Understanding the Function of HDL—Beyond Its Levels
Conference Presentation
Presence of Type 2 Diabetes (T2D) Affects HDL Particle Proteomic Composition Independently of Obesity or Fatty Liver
On-Demand Webinar
Early Identification of Type 2 Diabetes Risk for the Primary Care Setting

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only. May include AI-generated and/or AI-modified imagery.